The J.M. Smucker Company logo

The J.M. Smucker Company (SJM)

Market Open
21 Jul, 15:37
NYSE NYSE
$
113. 96
+1.46
+1.2978%
$
11.97B Market Cap
- P/E Ratio
4.4% Div Yield
332,301 Volume
9.61 Eps
$ 112.5
Previous Close
Add Transaction
Day Range
112.94 116
Year Range
88.25 119.39
Want to track SJM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Are SJM's Bold Portfolio Moves Paying Off in Core Segments?

Are SJM's Bold Portfolio Moves Paying Off in Core Segments?

The J. M. Smucker's strategic exits and Hostess buy show its push to streamline and lead in fast-growth categories.

Zacks | 1 year ago
The J. M. Smucker Slides 12% in a Month: How to Play SJM Stock

The J. M. Smucker Slides 12% in a Month: How to Play SJM Stock

SJM slides 12% in a month as weak snacks, costly coffee, and tariffs deepen pressure on margins and investor confidence.

Zacks | 1 year ago
J.M. Smucker to remove artificial food dyes by end-2027

J.M. Smucker to remove artificial food dyes by end-2027

Jif peanut butter maker J.M. Smucker said on Thursday it would remove synthetic food colors from all consumer food products by the end of 2027.

Reuters | 1 year ago
These 3 Consumer Staple Giants Are Oversold and Set to Skyrocket

These 3 Consumer Staple Giants Are Oversold and Set to Skyrocket

Below that level, this key momentum indicator signals that selling pressure has reached extreme levels and can often mark the point where the bears start to run out of steam. For contrarian investors, in particular, these oversold conditions can represent compelling buying opportunities, especially when they occur in established large-cap names.

Marketbeat | 1 year ago
The J. M. Smucker Stock Nears 52-Week Low: Opportunity or Red Flag?

The J. M. Smucker Stock Nears 52-Week Low: Opportunity or Red Flag?

SJM stock nears its 52-week low as weak pet food and snack sales, rising costs and tariffs pressure margins.

Zacks | 1 year ago
The Score: J.M. Smucker, Warner Bros.

The Score: J.M. Smucker, Warner Bros.

Here are some of the major companies whose stocks moved on the week's news

Wsj | 1 year ago
The J. M. Smucker Company (SJM) Q4 2025 Prerecorded Earnings Call Transcript

The J. M. Smucker Company (SJM) Q4 2025 Prerecorded Earnings Call Transcript

The J. M. Smucker Company (NYSE:SJM ) Q4 2025 Pre-Recorded Earnings Conference Call June 10, 2025 7:00 AM ET Company Participants Crystal Beiting - Vice President of Investor Relations and FP&A Mark T. Smucker - CEO & Chairman Tucker H.

Seekingalpha | 1 year ago
The J.M. Smucker Q4 Earnings Top Estimates, Sales Down 3% Y/Y

The J.M. Smucker Q4 Earnings Top Estimates, Sales Down 3% Y/Y

SJM's fourth-quarter results show mixed performance amid divestitures and acquisitions, with fiscal 2026 outlook guiding soft EPS.

Zacks | 1 year ago
Smucker (SJM) Reports Q4 Earnings: What Key Metrics Have to Say

Smucker (SJM) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Smucker (SJM) give a sense of how the business performed in the quarter ended April 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 1 year ago
The J. M. Smucker Company (SJM) Q4 2025 Earnings Conference Call Q&A Transcript

The J. M. Smucker Company (SJM) Q4 2025 Earnings Conference Call Q&A Transcript

The J. M. Smucker Company (NYSE:SJM ) Q4 2025 Earnings Conference Call June 10, 2025 9:00 AM ET Company Participants Crystal Beiting - Vice President of Investor Relations and FPandA Mark T. Smucker - CEO and Chairman Tucker H.

Seekingalpha | 1 year ago
J.M. Smucker Stock Hits 5-Year Low After Earnings

J.M. Smucker Stock Hits 5-Year Low After Earnings

Food and beverage stock J.M.

Schaeffersresearch | 1 year ago
J. M. Smucker: Further Disappointment Is Likely; Avoid Shares

J. M. Smucker: Further Disappointment Is Likely; Avoid Shares

The J. M. Smucker Company delivered a modest Q4 beat thanks to cost cuts, but sales growth was very disappointing. Higher coffee prices, increased pet food competition, and pressures from GLP-1 drugs will make the next 12 months difficult, and guidance appears too optimistic. At over 12x earnings, shares are not compelling, and I expect SJM to be dead money. Investors should look elsewhere for better opportunities.

Seekingalpha | 1 year ago
Loading...
Load More